NSE · BSE · Real-time
High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.
Gland Pharma has entered into a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical firm for a portfolio of sterile injectable products. This collaboration covers 55 SKUs across three manufacturing sites and is expected to generate approximately ₹902.5 crore in annualized revenue starting from 2029.
Real-time NSE & BSE event alerts, AI-summarized filings, and instant order-win signals — free for 15 days, no card required.
